Cutera, Inc. Announces Pricing of Public Offering of Common Stock

BRISBANE, Calif.--()--Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of an underwritten public offering of 2,385,000 shares of its common stock at a public offering price of $10.50 per share. The offering is expected to close on or about April 21, 2020, subject to the satisfaction of customary closing conditions. In connection with the offering, Cutera has granted the underwriter a 30-day option to purchase up to an additional 357,750 shares of common stock at the public offering price, less underwriting discounts and commissions.

Piper Sandler & Co. is acting as the sole book-running manager in the offering.

Cutera expects to receive gross proceeds of approximately $25.0 million. Cutera intends to use the net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by Cutera, to fund growth initiatives, market development activities related thereto and to provide for general corporate purposes, which may include working capital, capital expenditures, clinical trials other corporate expenses and acquisitions of complementary products, technologies or businesses. Cutera does not have agreements or commitments for any specific acquisitions at this time.

The shares of common stock are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-237552) previously filed with and declared effective by the Securities and Exchange Commission on April 14, 2020. A preliminary prospectus supplement and accompanying base prospectus relating to the offering, and a final prospectus supplement and accompanying base prospectus relating to the offering, each contain important information relating to the Cutera’s shares of common stock. A preliminary prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov. The final prospectus supplement and accompanying base prospectus will be filed with the SEC and available on the SEC’s website thereafter, and, when available, may also be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at 877-337-4747 or via email at prospectus@psc.com.

This press release shall not constitute an offer to sell nor the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Cutera, Inc.

Brisbane, California-based Cutera is a provider of energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit cutera.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Cutera cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in Cutera’s most recent annual report, any subsequent quarterly and current reports, and certain other filings, filed with the Securities and Exchange Commission. Cutera disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

Contacts

Cutera, Inc.
Anne Werdan
Director, Investor Relations
415-657-5500
awerdan@cutera.com

Contacts

Cutera, Inc.
Anne Werdan
Director, Investor Relations
415-657-5500
awerdan@cutera.com